Current Headlines
-
Association For Diagnostics & Laboratory Medicine (Formerly AACC) Submits Testimony To Congress Opposing FDA's Proposed LDTs Rule
3/21/2024
Statement attributable to: Octavia Peck Palmer, PhD President, Association for Diagnostics & Laboratory Medicine (formerly AACC)
-
World Precision Instruments Partners With TotalLab To Introduce 21 CFR Part 11 Into The EVOM Product Line
3/20/2024
World Precision Instruments (WPI) is pleased to announce their strategic partnership with TotalLab, paving the way for the integration of 21 CFR Part 11 compliance into its esteemed EVOM family of products.
-
Labcorp Launches pTau217 Blood Biomarker Test To Accelerate Path To Diagnosis of Alzheimer's Disease And Support Clinical Trials
3/20/2024
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch and immediate availability of its test to identify the presence or absence of phosphorylated tau 217 (pTau217), a pivotal blood biomarker designed to aid in the diagnosis of Alzheimer's disease and the subsequent monitoring of patients undergoing treatment with new Alzheimer's disease therapies.
-
Optimise The Global Medical Laboratory Workforce Through ASCP BOC Credentials
3/19/2024
The medical laboratory field is facing a significant global workforce challenge. This shortage is due to the recent and ongoing effects of a worldwide pandemic, recruitment, and retention opportunities, as well as increased demand for laboratory services.
-
QDx Pathology Services Adopts Proscia’s Software To Improve Speed And Precision
3/19/2024
QDx Pathology Services, an independent anatomical, molecular, and clinical pathology laboratory serving medical professionals and facilities throughout the United States, is working with Proscia®, a leading provider of digital and computational pathology solutions, to innovate its practice.
-
US BioTek Laboratories Expands Diagnostic Testing Portfolio With Acquisition Of RealTime Laboratories
3/19/2024
US BioTek Laboratories ("US BioTek"), a Clinical Laboratory Improvement Amendments (CLIA) and CAP accredited laboratory, announces the acquisition of Dallas, TX-based RealTime Laboratories ("RealTime"), a pioneer in the field of mycotoxin testing.
-
Genseq Selects Sapio LIMS To Power Best-In-Class Next-Generation Sequencing Services
3/18/2024
Genseq, a Dublin-based, CAP-accredited laboratory providing a range of services for biopharma and clinical research, has adopted the science-aware lab informatics platform from Sapio Sciences to manage its next-generation sequencing (NGS) and biobanking workflows.
-
Labcorp Presents New Research Demonstrating Clinical Impact Of Precision Diagnostics In Guiding Biomarker-Targeted Therapies For Patients With Epithelial Ovarian Cancer
3/16/2024
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today presented the results from two studies at the 2024 SGO Annual Meeting on Women's Cancer.
-
Revvity Introduces New Workflow To Accelerate Newborn Sequencing Research
3/15/2024
Revvity, Inc. today announced the introduction of a flexible end-to-end workflow solution for newborn research, enabling users to utilize different instruments, reagents and databases based on a lab’s needs.
-
Auburn Community Hospital (ACH) Is The First In The U.S. To Implement Abbott's Newest & Most Advanced Laboratory Technology
3/14/2024
Auburn Community Hospital (ACH) is the first institution in the United States to integrate Abbott's Alinity h‐series into the ACH Core Laboratory. This cutting-edge hematology automation system is set to transform the capabilities of the Auburn Laboratory.